Natrecor Sales & Marketing Subject Of Federal Prosecutor's Subpoena
This article was originally published in The Pink Sheet Daily
Executive Summary
U.S. Attorney's Office in Boston is seeking "documents related to the sales and marketing" of the congestive heart failure therapy, J&J division Scios says. Subpoena announcement comes on the heels of a journal article asserting that Scios engaged in a marketing campaign for outpatient use of the drug, which the company denies.